57 related articles for article (PubMed ID: 21263405)
1. Cystatin C in sera of patients with aggressive non-Hodgkin B-cell lymphoma.
Softić A; Begić L; Halilbasić A; Kos J
Med Glas (Zenica); 2011 Feb; 8(1):97-100. PubMed ID: 21263405
[TBL] [Abstract][Full Text] [Related]
2. Cystatin C as a potential marker for relapse in patients with non-Hodgkin B-cell lymphoma.
Mulaomerović A; Halilbasić A; Cickusić E; Zavasnik-Bergant T; Begić L; Kos J
Cancer Lett; 2007 Apr; 248(2):192-7. PubMed ID: 16945481
[TBL] [Abstract][Full Text] [Related]
3. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.
Kos J; Krasovec M; Cimerman N; Nielsen HJ; Christensen IJ; Brünner N
Clin Cancer Res; 2000 Feb; 6(2):505-11. PubMed ID: 10690531
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of serum levels of soluble intercellular adhesion molecules-1 in patients with primary extranodal non-Hodgkin lymphomas.
Lei KI; Johnson PJ
Cancer; 2000 Sep; 89(6):1387-95. PubMed ID: 11002235
[TBL] [Abstract][Full Text] [Related]
5. Serum cystatin C in patients with head and neck carcinoma.
Strojan P; Svetic B; Smid L; Kos J
Clin Chim Acta; 2004 Jun; 344(1-2):155-61. PubMed ID: 15149884
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of TNF alpha and its p55 soluble receptor in malignant lymphomas.
Warzocha K; Salles G; Bienvenu J; Barbier Y; Bastion Y; Doche C; Rieux C; Coiffier B
Leukemia; 1997 Apr; 11 Suppl 3():441-3. PubMed ID: 9209418
[TBL] [Abstract][Full Text] [Related]
8. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer.
Zore I; Krasovec M; Cimerman N; Kuhelj R; Werle B; Nielsen HJ; Brünner N; Kos J
Biol Chem; 2001 May; 382(5):805-10. PubMed ID: 11517934
[TBL] [Abstract][Full Text] [Related]
10. [Primary non-Hodgkin lymphoma of small bowel: a clinical analysis of 34 cases].
Chen CQ; Yin L; Peng CH; Zhao R; Chen GM; Zhou HJ; Li HW
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):249-52. PubMed ID: 17520384
[TBL] [Abstract][Full Text] [Related]
11. [Plasma interleukin-6 and interleukin-10 levels in different subtypes of lymphoma and their clinical significance].
Wang X; Zhao HR; Gu X; Liu P; Bikmituofu H
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1360-4. PubMed ID: 21868324
[TBL] [Abstract][Full Text] [Related]
12. Localized B-cell non-Hodgkin's lymphoma of oral cavity and maxillofacial region: a clinical study.
Kolokotronis A; Konstantinou N; Christakis I; Papadimitriou P; Matiakis A; Zaraboukas T; Antoniades D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):303-10. PubMed ID: 15716836
[TBL] [Abstract][Full Text] [Related]
13. The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer.
Nishikawa H; Ozaki Y; Nakanishi T; Blomgren K; Tada T; Arakawa A; Suzumori K
Gynecol Oncol; 2004 Mar; 92(3):881-6. PubMed ID: 14984956
[TBL] [Abstract][Full Text] [Related]
14. Significant elevation of plasma cathepsin B and cystatin C in patients with community-acquired pneumonia.
Lee YT; Chen SC; Shyu LY; Lee MC; Wu TC; Tsao SM; Yang SF
Clin Chim Acta; 2012 Mar; 413(5-6):630-5. PubMed ID: 22209964
[TBL] [Abstract][Full Text] [Related]
15. Low expression of dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin-related protein in non-Hodgkin lymphoma and significant correlations with lactic acid dehydrogenase and β2-microglobulin.
Zhang Z; Chen K; Yan L; Yang Z; Zhu Z; Chen C; Zeng J; Wei W; Qi X; Ren S; Zuo Y
Biochem Cell Biol; 2013 Aug; 91(4):214-20. PubMed ID: 23859015
[TBL] [Abstract][Full Text] [Related]
16. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of cystatin C in monitoring of B non-hodgkin lymphomas: relation to biochemical and clinical parameters.
Softić A; Begić L; Halilbašić A; Vižin T; Kos J
ISRN Oncol; 2013; 2013():752792. PubMed ID: 24167744
[TBL] [Abstract][Full Text] [Related]
18. Beta-2-microglobulin levels in patients with extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type: a retrospective analysis.
Penz MZ; Fiebiger WC; Valencak JB; Osterreicher C; Ba-Ssalamah A; Formanek M; Brodowic T; Chott A; Raderer M
Anticancer Res; 2001; 21(4B):3049-52. PubMed ID: 11712809
[TBL] [Abstract][Full Text] [Related]
19. Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications.
Tumminello FM; Flandina C; Crescimanno M; Leto G
Biomed Pharmacother; 2008 Feb; 62(2):130-5. PubMed ID: 17728092
[TBL] [Abstract][Full Text] [Related]
20. [Non Hodgkin lymphoma in the North-East Bosnia--changes in biological aggressiveness and primary presentation of the disease].
Halilbasić A; Mesic E; Cikusić E; Arnautović A
Med Arh; 2006; 60(6 Suppl 2):78-83. PubMed ID: 18172989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]